Target intelligence / Profile preview

Hematopoietic and Immune System Proteins

Molecular classification
Other
01

Overview

"Hematopoietic and immune system proteins" is a generic category encompassing a vast array of proteins involved in the formation (hematopoiesis) and function of the blood and immune systems. This includes molecules such as cytokines (chemical signals that coordinate immune activity), immunoglobulins (antibodies), complement proteins, cell surface antigens, receptors, signaling molecules, and enzymes, produced by or acting on hematopoietic and immune cells (such as lymphocytes, neutrophils, macrophages, T cells, B cells, and dendritic cells)[1][2][5][7]. The term does not refer to a specific molecular entity and cannot be used to uniquely identify a therapeutic target. For structured information, a more specific protein, gene or receptor name should be used (e.g., "Interleukin-6 receptor," "CD20," or "Immunoglobulin G") rather than this broad group categorization. Key rationale: - The term does *not* refer to a specific molecule or receptor, but to a diverse group of proteins with broad and varying roles in health and disease. - It cannot be considered an individual therapeutic target, although many actual targets are members of this group. - For drug discovery/prioritization or biomarker purposes, specific molecular names/abbreviations are essential. If you require structured information, please specify a distinct molecular target (e.g., "Interleukin-6," "CD19," "Toll-like receptor 4") within the hematopoietic or immune system protein families.

Other names
Hematopoietic proteinsImmune system proteinsHematopoietic/Immune factorsImmune-related proteins
02

Biological functions

HematopoiesisImmune responseSignal transductionCell proliferationApoptosisInflammationCell differentiation
03

Disease associations

CancerInflammationInfectionAutoimmune disordersImmunodeficienciesOther

Beyond the preview

Go deeper on Hematopoietic and Immune System Proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoietic and Immune System Proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call